Journal · Clinical reading · 7 min
Skin biopsies and dermal signalling: reading between the lines.
The mid-year note from the laboratory: what histology tells us about what our formulas are actually doing to tissue.
Dr Judey · Biomedical Emporium®
30 June 2026
Twice a year we look at histology from consenting volunteers who have been on our formulations for at least twelve weeks. It is the only way to check that what we see on the surface matches what is happening in the deeper layers.
The pattern that has held across every trial cohort is the same. Retinaldehyde produces a measurable thickening of the epidermis and a reorganisation of the dermal-epidermal junction. Peptide therapy produces new procollagen expression in the papillary dermis. The postbiotic complex reduces inflammatory cell infiltrate at the dermal boundary.
None of this is visible to the eye. It is what makes the eye-visible changes durable. We publish it because the customer deserves to know what the formula is actually doing inside the skin, not just on top of it.
Read next
A letter from the laboratory: the year ahead.
Dr Judey opens 2026 with a short note on what the laboratory is working on, and what it has decided to leave alone.